Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2021 1
2022 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean lavi, e (197 results)?
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.
Cortés J, Punie K, Barrios C, Hurvitz SA, Schneeweiss A, Sohn J, Tokunaga E, Brufsky A, Park YH, Xu B, Hegg R, Oliveira M, Fabi A, Vaksman N, Valdez T, Zhang X, Lai C, Tolaney SM; ASCENT-03 Clinical Trial Investigators. Cortés J, et al. N Engl J Med. 2025 Nov 13;393(19):1912-1925. doi: 10.1056/NEJMoa2511734. Epub 2025 Oct 19. N Engl J Med. 2025. PMID: 41124233 Clinical Trial.
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.
de Nonneville A, Salas S, Bertucci F, Sobinoff AP, Adélaïde J, Guille A, Finetti P, Noble JR, Churikov D, Chaffanet M, Lavit E, Pickett HA, Bouvier C, Birnbaum D, Reddel RR, Géli V. de Nonneville A, et al. Among authors: lavit e. EMBO Mol Med. 2022 Oct 10;14(10):e15859. doi: 10.15252/emmm.202215859. Epub 2022 Aug 3. EMBO Mol Med. 2022. PMID: 35920001 Free PMC article.
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group.
Lavit E, Aldea M, Piperno-Neumann S, Firmin N, Italiano A, Isambert N, Kurtz JE, Delcambre C, Lebrun V, Soibinet-Oudot P, Chevreau C, Bompas E, Le Maignan C, Boudou-Rouquette P, Le Cesne A, Mancini J, Blay JY, Duffaud F. Lavit E, et al. Int J Cancer. 2022 Feb 15;150(4):645-653. doi: 10.1002/ijc.33823. Epub 2021 Oct 5. Int J Cancer. 2022. PMID: 34562271
Clinical outcome of advanced or recurrent endometrial carcinoma treated with chemotherapy: a French observational retrospective cohort: the ENDOVIE study.
Alexandre J, Boudier P, Lavit E, Asselain B, Emambux S, Berton D, Babin G, Lescure C, Heudel PE, Salaun H, Delanoy N, Dawood H, Combe P, Duliège D, Selle F, Hakmé A, Cagnan L, Offner N, Niogret J, Pautier P, Sellam Z, Gomes David M, Monard A, Hardy-Bessard AC, Bellier C, Lortholary A, Chaix M, Follana P, Deiana L, Gavoille L, Manuceau G, Djennaoui S, Cancel M, Kalbacher E, De Percin S. Alexandre J, et al. Among authors: lavit e. BMJ Open. 2025 Sep 4;15(9):e096837. doi: 10.1136/bmjopen-2024-096837. BMJ Open. 2025. PMID: 40908005 Free PMC article.